Head-to-head

Berberine vs Canagliflozin

'Nature's Ozempic' against a real prescription SGLT2 drug with an actual, if mouse-only, longevity signal the OTC alternative doesn't have.

Berberine

Clinical data

Real (low-certainty) human evidence for glucose and lipids; the 'nature's Ozempic' weight-loss claim is not supported.

Full Berberine evidence review

Canagliflozin

Invokana

FDA-approved

FDA-approved SGLT2 inhibitor with real cardiovascular and renal outcome trials (CANVAS, CREDENCE) — but the longevity claim rests entirely on a 14% median-lifespan extension in male-only NIA ITP mice; no human longevity trial exists, and the drug carries real risks (amputation, Fournier's gangrene, euglycemic DKA) that apply the same whether it's prescribed for diabetes or taken off-label for aging.

Full Canagliflozin evidence review

Side by side

	Berberine	Canagliflozin
Marketed for	Blood sugar, lipids, 'nature's Ozempic'	Type 2 diabetes (approved); explored off-label for longevity on mouse ITP data
Evidence grade	Clinical data	FDA-approved
Family	Metabolic / AMPK	Metabolic / AMPK
Key human source	Meta-analysis, J Ethnopharmacol 2015	Miller 2020 NIA ITP, JCI Insight

marks a row where the two differ. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.

Our verdict

Berberine has real, low-certainty human evidence for glucose and lipids, but the 'nature's Ozempic' weight-loss framing is not supported by its trial record, and it has no mouse or human longevity data of its own. Canagliflozin is a stronger glucose-lowering drug with real cardiovascular/renal outcome trials (CANVAS, CREDENCE) and a genuine, repeatable NIA ITP mouse-lifespan signal — but it requires a prescription and carries real risks berberine doesn't, including amputation and Fournier's gangrene.

Berberine fits if

You want an OTC option for glucose/lipid support without a prescription, and you're not chasing a longevity signal specifically.

Canagliflozin fits if

Glycemic control is a genuine medical need best met with a prescription drug, or the ITP longevity signal specifically is what you're following, understood as mouse-only evidence.